CNS Pharmaceuticals Inc CNSP
$4.91
▼ -3.97%
($-0.20)
🎈 Low Float
Open
$4.91
Prev Close
$5.11
Day Range
$4.91 – $4.91
52W Range
$1.90 – $10.59
Market Cap
$7.17M
Beta
1.07
EPS (TTM)
$-23.14
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2019-11-08 |
| Shares Out. | 1,460,000 |
| Website | cnspharma.com/ ↗ |
| Phone | 18009469185 |
| Employees | 8 |
| Revenue | $0 |
| Gross Profit | $0 |
| Net Income | -$2.6M |
| Free Cash Flow | -$13.4M |
| Total Assets | $21.9M |
| Total Liabilities | $3.7M |
| Equity | $18.2M |
About CNS Pharmaceuticals Inc
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.
CNS Pharmaceuticals Inc is a publicly traded company under the ticker symbol CNSP on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
7 analysts (2026-09-01)